LMBAX
Price
$14.94
Change
+$0.55 (+3.82%)
Updated
Aug 22 closing price
Net Assets
114.02M
VSMAX
Price
$120.98
Change
+$3.56 (+3.03%)
Updated
Aug 22 closing price
Net Assets
154.18B
Interact to see
Advertisement

LMBAX vs VSMAX

Header iconLMBAX vs VSMAX Comparison
Open Charts LMBAX vs VSMAXBanner chart's image
Franklin U.S. Small Cap Equity A
Price$14.94
Change+$0.55 (+3.82%)
VolumeN/A
Net Assets114.02M
Vanguard Small Cap Index Admiral Shares
Price$120.98
Change+$3.56 (+3.03%)
VolumeN/A
Net Assets154.18B
LMBAX vs VSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMBAX vs. VSMAX commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMBAX is a Buy and VSMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 154B vs. LMBAX (114M). VSMAX pays higher dividends than LMBAX: VSMAX (1.37) vs LMBAX (0.30). LMBAX was incepted earlier than VSMAX: LMBAX (17 years) vs VSMAX (25 years). LMBAX (1.41) is less costly to investors than VSMAX (0.05). LMBAX is a more actively managed with annual turnover of: 53.00 vs. VSMAX (13.00). LMBAX has a lower initial minimum investment than VSMAX: LMBAX (1000) vs VSMAX (3000). LMBAX (11.65) and VSMAX (11.21) have marching annual gain over last year. VSMAX return over 5 years is better than : 64.15 vs. LMBAX (39.91).
LMBAXVSMAXLMBAX / VSMAX
Total Expense Ratio1.300.052,600%
Annual Report Gross Expense Ratio1.410.052,820%
Fund Existence17 years25 years-
Gain YTD12.3315.231236%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets114M154B0%
Annual Yield % from dividends0.301.3722%
Returns for 1 year11.6511.21104%
Returns for 3 years25.6829.9886%
Returns for 5 years39.9164.1562%
Returns for 10 years23.59142.1017%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQQ30.812.19
+7.65%
Arqit Quantum Inc
OVID1.030.07
+7.63%
Ovid Therapeutics
PBI11.820.52
+4.60%
Pitney Bowes
VRAX0.760.02
+3.21%
Virax Biolabs Group Limited
CR194.235.53
+2.93%
Crane Company